FOXO3 and chronic myelogenous leukemia, BCR-ABL1 positive: It was reported that prolonged FOXO3a activity can cause the resistance to doxorubicin in breast cancer cells and a similar effect was shown in chronic myelogenous leukemia cells [28, 29].